127 related articles for article (PubMed ID: 7913221)
1. Redesign of the substrate specificity of human cathepsin D: the dominant role of position 287 in the S2 subsite.
Scarborough PE; Dunn BM
Protein Eng; 1994 Apr; 7(4):495-502. PubMed ID: 7913221
[TBL] [Abstract][Full Text] [Related]
2. Exploration of subsite binding specificity of human cathepsin D through kinetics and rule-based molecular modeling.
Scarborough PE; Guruprasad K; Topham C; Richo GR; Conner GE; Blundell TL; Dunn BM
Protein Sci; 1993 Feb; 2(2):264-76. PubMed ID: 8443603
[TBL] [Abstract][Full Text] [Related]
3. Engineering the S2 subsite specificity of human cathepsin S to a cathepsin L- and cathepsin B-like specificity.
Brömme D; Bonneau PR; Lachance P; Storer AC
J Biol Chem; 1994 Dec; 269(48):30238-42. PubMed ID: 7982933
[TBL] [Abstract][Full Text] [Related]
4. Recombinant expression and enzymatic subsite characterization of plasmepsin 4 from the four Plasmodium species infecting man.
Li T; Yowell CA; Beyer BB; Hung SH; Westling J; Lam MT; Dunn BM; Dame JB
Mol Biochem Parasitol; 2004 May; 135(1):101-9. PubMed ID: 15287591
[TBL] [Abstract][Full Text] [Related]
5. Prime region subsite specificity characterization of human cathepsin D: the dominant role of position 128.
Beyer BM; Dunn BM
Protein Sci; 1998 Jan; 7(1):88-95. PubMed ID: 9514263
[TBL] [Abstract][Full Text] [Related]
6. Ov-APR-1, an aspartic protease from the carcinogenic liver fluke, Opisthorchis viverrini: functional expression, immunolocalization and subsite specificity.
Suttiprapa S; Mulvenna J; Huong NT; Pearson MS; Brindley PJ; Laha T; Wongkham S; Kaewkes S; Sripa B; Loukas A
Int J Biochem Cell Biol; 2009 May; 41(5):1148-56. PubMed ID: 18996218
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of the collagenolytic activity of human cathepsin K by altering its S2 subsite specificity.
Lecaille F; Choe Y; Brandt W; Li Z; Craik CS; Brömme D
Biochemistry; 2002 Jul; 41(26):8447-54. PubMed ID: 12081494
[TBL] [Abstract][Full Text] [Related]
8. The two sides of enzyme-substrate specificity: lessons from the aspartic proteinases.
Dunn BM; Hung S
Biochim Biophys Acta; 2000 Mar; 1477(1-2):231-40. PubMed ID: 10708860
[TBL] [Abstract][Full Text] [Related]
9. S3 to S3' subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates.
Alves MF; Puzer L; Cotrin SS; Juliano MA; Juliano L; Brömme D; Carmona AK
Biochem J; 2003 Aug; 373(Pt 3):981-6. PubMed ID: 12733990
[TBL] [Abstract][Full Text] [Related]
10. Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease.
Chan VJ; Selzer PM; McKerrow JH; Sakanari JA
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):113-7. PubMed ID: 10229665
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cathepsin B specificity by site-directed mutagenesis. Importance of Glu245 in the S2-P2 specificity for arginine and its role in transition state stabilization.
Hasnain S; Hirama T; Huber CP; Mason P; Mort JS
J Biol Chem; 1993 Jan; 268(1):235-40. PubMed ID: 8093241
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin D displays in vitro beta-secretase-like specificity.
Chevallier N; Vizzavona J; Marambaud P; Baur CP; Spillantini M; Fulcrand P; Martinez J; Goedert M; Vincent JP; Checler F
Brain Res; 1997 Mar; 750(1-2):11-9. PubMed ID: 9098524
[TBL] [Abstract][Full Text] [Related]
13. Sequence, expression and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum.
Dame JB; Reddy GR; Yowell CA; Dunn BM; Kay J; Berry C
Mol Biochem Parasitol; 1994 Apr; 64(2):177-90. PubMed ID: 7935597
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic enzymes in yolk-sac membrane of quail egg. Purification and enzymatic characterisation.
Gerhartz B; Auerswald EA; Mentele R; Fritz H; Machleidt W; Kolb HJ; Wittmann J
Comp Biochem Physiol B Biochem Mol Biol; 1997 Sep; 118(1):159-66. PubMed ID: 9418005
[TBL] [Abstract][Full Text] [Related]
15. Comparison of kinetic properties of native and recombinant human cathepsin D.
Scarborough PE; Richo GR; Kay J; Conner GE; Dunn BM
Adv Exp Med Biol; 1991; 306():343-7. PubMed ID: 1812725
[No Abstract] [Full Text] [Related]
16. Exploring the binding preferences/specificity in the active site of human cathepsin E.
Rao-Naik C; Guruprasad K; Batley B; Rapundalo S; Hill J; Blundell T; Kay J; Dunn BM
Proteins; 1995 Jun; 22(2):168-81. PubMed ID: 7567964
[TBL] [Abstract][Full Text] [Related]
17. Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design.
Baldwin ET; Bhat TN; Gulnik S; Hosur MV; Sowder RC; Cachau RE; Collins J; Silva AM; Erickson JW
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6796-800. PubMed ID: 8393577
[TBL] [Abstract][Full Text] [Related]
18. A single amino acid substitution affects substrate specificity in cysteine proteinases from Fasciola hepatica.
Smooker PM; Whisstock JC; Irving JA; Siyaguna S; Spithill TW; Pike RN
Protein Sci; 2000 Dec; 9(12):2567-72. PubMed ID: 11206078
[TBL] [Abstract][Full Text] [Related]
19. Engineering the substrate specificity of rhizopuspepsin: the role of Asp 77 of fungal aspartic proteinases in facilitating the cleavage of oligopeptide substrates with lysine in P1.
Lowther WT; Majer P; Dunn BM
Protein Sci; 1995 Apr; 4(4):689-702. PubMed ID: 7613467
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the S1 subsite specificity of aspergillopepsin I by site-directed mutagenesis.
Shintani T; Kobayashi M; Ichishima E
J Biochem; 1996 Nov; 120(5):974-81. PubMed ID: 8982865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
